Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$42.05 - $47.77 $14,717 - $16,719
-350 Reduced 38.46%
560 $24,000
Q1 2022

Apr 22, 2022

BUY
$40.23 - $47.74 $18,304 - $21,721
455 Added 100.0%
910 $40,000
Q3 2021

Oct 21, 2021

SELL
$38.79 - $43.16 $1.22 Million - $1.35 Million
-31,351 Reduced 98.57%
455 $17,000
Q2 2021

Jul 22, 2021

BUY
$36.52 - $41.46 $27,061 - $30,721
741 Added 2.39%
31,806 $1.2 Million
Q1 2021

May 03, 2021

SELL
$34.27 - $40.01 $45,442 - $53,053
-1,326 Reduced 4.09%
31,065 $1.11 Million
Q4 2020

Feb 01, 2021

BUY
$34.07 - $39.94 $19,930 - $23,364
585 Added 1.84%
32,391 $1.19 Million
Q3 2020

Oct 19, 2020

SELL
$38.11 - $42.99 $73,323 - $82,712
-1,924 Reduced 5.7%
31,806 $1.2 Million
Q2 2020

Jul 17, 2020

SELL
$37.87 - $43.58 $130,765 - $150,481
-3,453 Reduced 9.29%
33,730 $1.38 Million
Q1 2020

Apr 24, 2020

BUY
$32.47 - $48.83 $48,867 - $73,489
1,505 Added 4.22%
37,183 $1.44 Million
Q4 2019

Jan 16, 2020

BUY
$42.0 - $48.25 $25,032 - $28,757
596 Added 1.7%
35,678 $1.68 Million
Q3 2019

Oct 18, 2019

BUY
$40.46 - $43.52 $37,304 - $40,125
922 Added 2.7%
35,082 $1.5 Million
Q2 2019

Jul 18, 2019

BUY
$39.4 - $42.7 $16,390 - $17,763
416 Added 1.23%
34,160 $1.37 Million
Q1 2019

Apr 23, 2019

SELL
$38.57 - $42.69 $30,007 - $33,212
-778 Reduced 2.25%
33,744 $0
Q4 2018

Jan 31, 2019

BUY
$37.8 - $42.69 $59,043 - $66,681
1,562 Added 4.74%
34,522 $1.32 Million
Q3 2018

Oct 24, 2018

BUY
$39.75 - $42.69 $8,705 - $9,349
219 Added 0.67%
32,960 $0
Q2 2018

Aug 08, 2018

SELL
$39.61 - $42.76 $73,516 - $79,362
-1,856 Reduced 5.36%
32,741 $1.32 Million
Q1 2018

May 10, 2018

BUY
$36.18 - $40.15 $357,024 - $396,200
9,868 Added 39.9%
34,597 $1.35 Million
Q4 2017

Jan 25, 2018

SELL
$35.34 - $41.9 $56,190 - $66,621
-1,590 Reduced 6.04%
24,729 $877,000
Q3 2017

Oct 26, 2017

BUY
$39.44 - $41.55 $1.04 Million - $1.09 Million
26,319
26,319 $0

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Hanson & Doremus Investment Management Portfolio

Follow Hanson & Doremus Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.